TRANSCAT INC (TRNS) Fundamental Analysis & Valuation

NASDAQ:TRNS • US8935291075

Current stock price

73.45 USD
+3 (+4.26%)
At close:
73.45 USD
0 (0%)
After Hours:

This TRNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. TRNS Profitability Analysis

1.1 Basic Checks

  • TRNS had positive earnings in the past year.
  • TRNS had a positive operating cash flow in the past year.
  • In the past 5 years TRNS has always been profitable.
  • TRNS had a positive operating cash flow in each of the past 5 years.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • TRNS has a Return On Assets (1.67%) which is comparable to the rest of the industry.
  • TRNS's Return On Equity of 2.66% is in line compared to the rest of the industry. TRNS outperforms 44.68% of its industry peers.
  • TRNS has a Return On Invested Capital (3.14%) which is in line with its industry peers.
  • TRNS had an Average Return On Invested Capital over the past 3 years of 6.00%. This is below the industry average of 9.00%.
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROIC 3.14%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of TRNS (2.47%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of TRNS has grown nicely.
  • TRNS has a Operating Margin of 5.60%. This is comparable to the rest of the industry: TRNS outperforms 55.32% of its industry peers.
  • TRNS's Operating Margin has improved in the last couple of years.
  • TRNS has a better Gross Margin (32.45%) than 63.83% of its industry peers.
  • TRNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. TRNS Health Analysis

2.1 Basic Checks

  • TRNS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TRNS has more shares outstanding
  • TRNS has more shares outstanding than it did 5 years ago.
  • TRNS has a worse debt/assets ratio than last year.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • TRNS has an Altman-Z score of 3.44. This indicates that TRNS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.44, TRNS is in the better half of the industry, outperforming 63.83% of the companies in the same industry.
  • The Debt to FCF ratio of TRNS is 4.02, which is a neutral value as it means it would take TRNS, 4.02 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of TRNS (4.02) is better than 68.09% of its industry peers.
  • TRNS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.34, TRNS is doing good in the industry, outperforming 61.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Altman-Z 3.44
ROIC/WACC0.36
WACC8.85%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • TRNS has a Current Ratio of 2.21. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
  • TRNS's Current ratio of 2.21 is fine compared to the rest of the industry. TRNS outperforms 61.70% of its industry peers.
  • A Quick Ratio of 1.85 indicates that TRNS should not have too much problems paying its short term obligations.
  • TRNS has a Quick ratio of 1.85. This is amongst the best in the industry. TRNS outperforms 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.85
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRNS Growth Analysis

3.1 Past

  • The earnings per share for TRNS have decreased by -9.19% in the last year.
  • The Earnings Per Share has been growing slightly by 6.36% on average over the past years.
  • The Revenue has grown by 17.45% in the past year. This is quite good.
  • The Revenue has been growing by 9.97% on average over the past years. This is quite good.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%

3.2 Future

  • Based on estimates for the next years, TRNS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.15% on average per year.
  • The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y28.71%
EPS Next 2Y25.5%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. TRNS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 43.72, which means the current valuation is very expensive for TRNS.
  • Compared to the rest of the industry, the Price/Earnings ratio of TRNS is on the same level as its industry peers.
  • TRNS is valuated expensively when we compare the Price/Earnings ratio to 24.75, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 31.72, the valuation of TRNS can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as TRNS.
  • When comparing the Price/Forward Earnings ratio of TRNS to the average of the S&P500 Index (22.10), we can say TRNS is valued slightly more expensively.
Industry RankSector Rank
PE 43.72
Fwd PE 31.72
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TRNS is on the same level as its industry peers.
  • TRNS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TRNS is cheaper than 74.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.55
EV/EBITDA 17.63
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of TRNS may justify a higher PE ratio.
  • TRNS's earnings are expected to grow with 17.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.52
PEG (5Y)6.87
EPS Next 2Y25.5%
EPS Next 3Y17.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRNS Dividend Analysis

5.1 Amount

  • No dividends for TRNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRNS Fundamentals: All Metrics, Ratios and Statistics

TRANSCAT INC

NASDAQ:TRNS (3/31/2026, 4:30:01 PM)

After market: 73.45 0 (0%)

73.45

+3 (+4.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners96.34%
Inst Owner Change0.55%
Ins Owners0.98%
Ins Owner Change0%
Market Cap685.29M
Revenue(TTM)319.69M
Net Income(TTM)7.89M
Analysts80
Price Target103.36 (40.72%)
Short Float %5.72%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.05%
Min EPS beat(2)-23.53%
Max EPS beat(2)-14.58%
EPS beat(4)2
Avg EPS beat(4)2.74%
Min EPS beat(4)-23.53%
Max EPS beat(4)46.44%
EPS beat(8)4
Avg EPS beat(8)4.49%
EPS beat(12)7
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)2
Avg Revenue beat(2)0.8%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.01%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.56%
Revenue beat(12)6
Avg Revenue beat(12)-1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)-2.25%
PT rev (3m)-2.25%
EPS NQ rev (1m)-4.97%
EPS NQ rev (3m)-14.23%
EPS NY rev (1m)-4.87%
EPS NY rev (3m)-12.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 43.72
Fwd PE 31.72
P/S 2.14
P/FCF 27.55
P/OCF 17.45
P/B 2.31
P/tB N/A
EV/EBITDA 17.63
EPS(TTM)1.68
EY2.29%
EPS(NY)2.32
Fwd EY3.15%
FCF(TTM)2.67
FCFY3.63%
OCF(TTM)4.21
OCFY5.73%
SpS34.26
BVpS31.81
TBVpS-0.29
PEG (NY)1.52
PEG (5Y)6.87
Graham Number34.67
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROCE 4.1%
ROIC 3.14%
ROICexc 3.17%
ROICexgc 10.29%
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
FCFM 7.78%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Debt/EBITDA 2.34
Cap/Depr 57.97%
Cap/Sales 4.51%
Interest Coverage 250
Cash Conversion 91.87%
Profit Quality 315.12%
Current Ratio 2.21
Quick Ratio 1.85
Altman-Z 3.44
F-Score4
WACC8.85%
ROIC/WACC0.36
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y28.71%
EPS Next 2Y25.5%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%
EBIT growth 1Y-18.8%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year192.7%
EBIT Next 3Y47.62%
EBIT Next 5Y32.49%
FCF growth 1Y34.44%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y31.51%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS Fundamental Analysis FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 5 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 3 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 43.72 and the Price/Book (PB) ratio is 2.31.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 6 / 10.